3. Research Infrastructures

EN

Horizon Europe

Work Programme 2021-2022

3. Research Infrastructures

(European Commission Decision C(2021)1940 of 31 March 2021)

Horizon Europe - Work Programme 2021-2022

Research Infrastructures

Part 3 - Page 2 of 17

Table of contents

Introduction ............................................................................................ 3

Other Actions not subject to calls for proposals......................................... 4

1. FAIR and open data sharing in support to European preparedness for COVID-19 and

other infectious diseases ...................................................................................................4

2. Research infrastructure services for rapid research responses to COVID-19 and other

infectious disease epidemics .............................................................................................8

Budget .................................................................................................. 14

Specific Features for Research Infrastructure ......................................... 15




Introduction

The overall objective of the Research Infrastructures Programme under Horizon Europe is to

empower Europe through world-class and accessible research infrastructures.

Research infrastructures (RIs), including the European Open Science Cloud (EOSC), are

crucial enablers of research and technological innovation and drivers of multidisciplinary and

data-intensive science.

Europe has a rich landscape of research infrastructures, which has the potential to enhance

society’s long term and consistent problem-solving capacity and ensure the provision of

customised, multidisciplinary, impact-oriented and integrated RI services and resources to

support an effective and responsive health system. In this regard, Research Infrastructures can

substantially contribute to the objectives of Horizon Europe clusters.

On 30 January 2020 the World Health Organisation declared the COVID-19 outbreak a public

health emergency of international concern.

One year later, the pandemic is still not under control.

While vaccines against the COVID-19 disease are now becoming available and being used,

variants of the causative virus pathogen (SARS-CoV-2) are increasingly of concern, because

of their impact on transmissibility, severity of disease and vaccine effectiveness.

As outlined in the Commission Communication ‘HERA Incubator: Anticipating together the

threat of COVID-19 variants’1, an additional concerted EU effort is needed to further speed

up the process of understanding the occurrence and spread of variants and their effect on

disease severity and vaccine effectiveness.

For this reason, this work programme will open in 2021 two specific actions aiming at

mobilising research infrastructures in response to infectious disease epidemics and future

emerging pathogens of concern, and, as a first challenge, at supporting and enabling a rapid

research response to the spread of SARS-CoV-2 variants and to the COVID-19 pandemic:

FAIR2 and open data sharing in support to European preparedness for COVID-19 and

other infectious diseases

Research infrastructure services for rapid research responses to COVID-19 and other

infectious disease epidemics

1 COM(2021)78 final of 17 February 2021, https://ec.europa.eu/info/sites/info/files/communication-hera-incubator-anticipating-threat-covid-19-variants_en.pdf 2 Findable, Accessible, Interoperable, Reusable, https://www.go-fair.org/fair-principles/

https://ec.europa.eu/info/sites/info/files/communication-hera-incubator-anticipating-threat-covid-19-variants_en.pdf

https://ec.europa.eu/info/sites/info/files/communication-hera-incubator-anticipating-threat-covid-19-variants_en.pdf

https://www.go-fair.org/fair-principles/




Other Actions not subject to calls for proposals

1. FAIR and open data sharing in support to European preparedness for COVID-19 and

other infectious diseases

As part of the EU response to the COVID-19 pandemic, and to the rising spread of SARS-

CoV-2 variants, grants will be awarded without a ca ll for proposal in accordance with Article

195 (b) of the Financial Regulation 2018/1046 to address this exceptional emergency. An

invitation to apply for funding will be published on the Funding & Tenders Portal that will

open a dedicated section where proposals can be submitted. This will be communicated to the

National Contact Points. The invitation to apply for funding will be open to all eligible

entities or limited to targeted entities, taking into account the need to achieve the underlying

objectives in a quick and efficient manner considering the exceptional circumstances

(’extreme urgency’ due the COVID-19 pandemic).

Expected Outcome: Project results are expected to contribute to all the following expected

outcomes:

European researchers and public health actors fighting the spread of infectious diseases,

e.g. COVID-19 and emerging infectious diseases are able to store, share, access, analyse,

process and cite research and clinical data and other research digital objects across

disciplines and national borders and to collaborate with global partners;

federation of viral and human infectious disease data from national and international

centres enables pan-European and global sharing and combination of research and

clinical data, thereby catalysing and accelerating research advances to combat the

COVID-19 pandemic and prepare for future outbreaks;

development of digital tools and data analytics for pandemic and outbreak preparedness,

including tracking genomic variations of SARS-CoV-2, linking genomic and clinical

data to support timely identification of variants of concern, and subsequent rapid

characterisation of such strains to inform public health action;

linking of FAIR data and metadata on SARS-CoV-2 and COVID-19, on other related

viruses and diseases, and on socio-economic consequences, across research fields, from

omics, clinical, and epidemiological research, to Social Sciences and Humanities

accelerate infectious disease research, surveillance and outbreak investigation;

contribute to the Horizon Europe European Open Science Cloud (EOSC) Partnership

and to the development of the European Health Data Space (EHDS).

Expected impact

Proposals should set out a credible pathway to contributing to one or several of the following

impacts:




transforming the way researchers as well as relevant actors in the public and private

sectors create, share and exploit research outputs (data, publications, protocols,

methodologies, software, code, etc.) within and across research disciplines, and with the

public health sector, leading to improved timeliness, better quality, more innovation,

higher productivity of research and a better integration between research outputs and

public health policy;

seamless access to and management of increasing volumes of research data following

FAIR principles (and that are as open as possible , as closed as necessary) and other

research outputs stimulating the development and uptake of a wide range of new

innovative and value-added services from public and commercial providers;

improving trust in science through increased FAIRness, openness and quality of

scientific research in Europe, supported by more meaningful monitoring and better

facilitators for reproducibility, validation and re-use of research results, and by

improving pathways for the communication of science to the public.

Scope: This action responds to the need to enable researchers, health care professionals and

society at large to share, access, analyse, link and process research data and other research

digital objects across disciplines and national borders in response to the COVID-19 pandemic.

As seen with other infectious disease outbreaks, such as haemorrhagic fevers, COVID-19 will

likely remain a societal challenge beyond the immediate outbreak, considering its destructive

and disruptive impact on healthcare systems and the economy. In addition to the ongoing

health threat from SARS-CoV-2, the risk from other emerging pathogens also persists, which

will also require similar concerted action to identify and characterise infections with

pandemic potential, and enable rapid public health action to mitigate health and societal

impact. Provision of comprehensive open data on infectious agents and diseases during

outbreaks support evidence-based quality assessment - across scientific, medical, public

health and policy domains and promotes reproducibility of research outcomes. Particular

importance should be placed on mobilising raw viral sequences and identifying and

monitoring the spread of SARS-CoV-2 variants. European readiness for future pandemics is

of utmost importance and should be addressed to ensure the preparedness of infrastructure

building on already existing frameworks for broader use such as the EOSC.

Proposals should facilitate and accelerate the access to, and the linking of data and metadata

on SARS-CoV-2 and COVID-19, including through the European COVID-19 Data Portal3,

the Versatile Emerging infectious disease Observatory4 (VEO) and other relevant initiatives,

with the emphasis on identifying and tracking of new SARS-CoV-2 variants and creating

appropriate links with serology and other host data. The scope of the initiative should further

expand to other relevant infectious diseases, and incorporate epidemiological, clinical

(including Real World Data), and socio-economic data, spanning from molecular biology to

other disciplines, including Social Sciences and Humanities. A One-Health approach building

on the latest technological advances, covering epidemics and epizootics is encouraged.

3 https://www.covid19dataportal.org 4 https://www.veo-europe.eu/

https://www.covid19dataportal.org/

https://www.veo-europe.eu/




Particular importance should be given to the need of federating data between national centres

to effectively manage data protection.

To ensure the interoperability of the data, community best practices including the use of

community-endorsed standards and community metadata schemas should be encouraged.

Newly implemented domain specific research data solutions from the project should feed into

the work of established international initiatives. Particular attention should be given to the

harmonisation and management of meta-data and sample- identifiers to ensure interoperability

of national and regional efforts into the EOSC and the long-term cataloguing of data resources

within the EOSC.

A strong focus should be placed on exploiting and contributing to EOSC capabilities for data

access and federation as well as relevant standards and policies for managing, sharing and

reusing research data from different disciplines. As such, the proposals should demonstrate

the value of sharing FAIR research data that is as open as possible through EOSC, help

consolidating data-sharing and data management practices across the Member States,

Associated Countries and beyond, and provide feedback to the EOSC Partnership for the

future evolution of EOSC.

Proposals should build on the European COVID-19 Data Platform5 and support, directly or in

combination with financial support to third parties, the creation of national and regional

structures to coordinate and promote in-country actions, such as to further enhance genomic

surveillance and rapid-response capabilities.

Cooperation with the grant awarded under the Other action “Research infrastructure services

for rapid research responses to COVID-19 and other infectious disease epidemics” should be

developed from the outset to identify and better exploit related synergies, share results, avoid

overlaps and ensure that data generated from access to infectious disease services can be

available for re-use through the EOSC. To this extent, proposals should provide for dedicated

activities and earmark appropriate resources. Proposals should consider already established

national and European infrastructures and build on existing efforts, including actions

stemming from Cohesion policy programmes. Proposals should seek to establish synergies

with the European Health Data Space as well as relevant initiatives under Digital Europe.

To ensure complementarity of outcomes, alignment with EOSC policies, and a synergetic

development of different thematic areas within EOSC, proposals are expected to cooperate

and align with activities of the EOSC Partnership and to coordinate with relevant initiatives

and projects contributing to the development of EOSC, particularly in the areas of data

interoperability.

All software developed under this action should be open source, licensed under a CC0 public

domain dedication or under an open source license as recommended by the Free Software

Foundation and the Open Source Initiative.

5 https://www.covid19dataportal.org

https://www.covid19dataportal.org/




This action seeks to address the challenges linked to the COVID-19 variants. As such, the

granting authority hereby requests activation of the public emergency provisions, meaning

that the beneficiaries must comply with the public emergency related provisions listed in the

General Annexes concerning the project implementation under - Intellectual Property Rights

(IPR), background and results, access rights and rights of use (article 16 and Annex 5) for the

duration of the pandemic; and under Communication, dissemination, open science and

visibility (article 17 and Annex 5) during the entire duration of the action and for four years

after the end of the action.

Specific Conditions

The general conditions, including admissibility conditions, eligibility conditions, award

criteria, evaluation and award procedure, legal and financial set-up for grants, financial and

operational capacity and exclusion, and procedure are provided in parts A to G of the General

Annexes. The following topic specific conditions apply:

Eligibility conditions

Due to the urgency of this action and geographical relevance of this action and considering

the Union’s interest to retain, in principle, relations with the countries associated to Horizon

2020, and other third countries in the process of association to Horizon Europe, legal entities

established in Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland,

Israel, Kosovo 6 , Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia,

Switzerland, Tunisia, Turkey, Ukraine and United Kingdom are eligible for funding from the

Union even if the Horizon Europe association agreement with the third country concerned

does not apply at the time of signature of the grant agreement.

The consortium must include at least one independent legal entity established in a Member

State and at least two other independent legal entities each established in different Member

States or countries listed above.

Award criteria

Additional sub-criterion for Impact:

The extent to which the proposed work incorporates the necessary resources and efforts

to coordinate with other relevant projects and the EOSC governance structure in the

context of the EOSC Partnership.

Procedure

The granting authority can fund a maximum of one project.

Legal and financial set-up of the Grant Agreements

6 This designation is without prejudice to positions on status, and is in line with UNSCR 1244/1999 and

the ICJ Opinion on the Kosovo declaration of independence.




Beneficiaries may provide financial support to third parties. The support to third parties can

only be provided in the form of grants.

Beneficiaries must deposit the digital research data generated in the action in a trusted

repository federated in the EOSC in compliance with EOSC requirements.

Beneficiaries will be subject to the additional access rights: each beneficiary must grant

royalty-free access to its results to the EOSC Association for monitoring and developing

policies and strategies for the European Open Science Cloud.

Form of Funding: Grants not subject to calls for proposals

Type of Action: Research and Innovation Actions - Grant awarded without call for proposals

in accordance with Article 195 (b) of the Financial Regulation

Indicative timetable: Second quarter 2021

Indicative budget: EUR 12.00 million from the 2021 budget

2. Research infrastructure services for rapid research responses to COVID-19 and other

infectious disease epidemics

As part of the EU response to the COVID-19 pandemic, and to the rising spread of SARS-

CoV-2 variants, grants will be awarded without a call for proposal in accordance with Article

195 (b) of the Financial Regulation 2018/1046 to address this exceptional emergency. An

invitation to apply for funding will be published on the Funding & Tenders Portal that will

open a dedicated section where proposals can be submitted. This will be communicated to the

National Contact Points. The invitation to apply for funding will be open to all eligible

entities or limited to targeted entities, taking into account the need to achieve the underlying

objectives in a quick and efficient manner considering the exceptional circumstances

(‘extreme urgency’ due the COVID-19 pandemic).

Expected Outcome: Project results are expected to contribute to all the following expected

outcomes:

comprehensive catalogue of research infrastructure services relevant to tackle infectious

diseases epidemics is available, including services supporting pertinent social sciences

research;

fast assembly and provision of innovative, customised and efficient research

infrastructure services to support research linked to detecting, assessing and combatting

newly emerging SARS-CoV-2 variants;

challenge driven integration of research infrastructures to better support research

addressing infectious diseases and face epidemics, including for use by epidemics risk

assessment and risk management bodies (such as the European Centre for Disease

prevention and Control (ECDC), the World Health Organisation (WHO), the World

Organisation of Animal Health (OIE) and national epidemics management bodies);




rapid response to epidemics outbreaks through research infrastructure services

underpinning and supporting research aiming to understand causes and development of

the epidemic;

development of novel/adapted epidemics intervention tools and measures enabled by

relevant research infrastructure (RI) services;

availability of research data emerging from access provision activities for re-use on

common data platforms and registries, according to FAIR principles and compliant with

legal provisions under the General Data Protection Regulation (GDPR).

Expected Impact: Proposals should set out a credible pathway to contributing to several of the

following impacts

enhancement of EU capacity to identify, characterise and mitigate the effects of COVID-

19 virus variants of concern, and future emerging pathogens of public health concern;

reinforced research infrastructures capacity to provide at scale and across the EU

services to support excellent research to address societal challenges, and Horizon Europe

objectives;

enhanced and increased society’s long-term and consistent problem-solving capacity and

evidence-based policy making in areas linked to health, including a better understanding

of socio-economic implications, through the provision of innovative, customised and

efficient RI services;

new discoveries and knowledge breakthroughs enabled by access provision to the best

and in some cases unique state-of-the-art RIs;

a new generation of researchers trained to optimally exploit all the essential and

advanced tools for their research.

Scope: Proposals under this action, will integrate research infrastructure services to form a

comprehensive and inclusive portfolio to support research in response to infectious disease

epidemics or underpinning respective forefront research in the field. As a first immediate

challenge, the delivered services should support research targeting newly emerging SARS-

Cov-2 variants and addressing the on-going COVID-19 pandemic.

Proposals will support the provision of trans-national and/or virtual access to researchers as

well as training for using the infrastructures, and activities to improve, customise and

integrate the services the infrastructures provide, so as to facilitate and integrate the access

procedures and to further develop the remote or virtual provision of services.

Access to research infrastructure services will be provided to users to support their research

projects targeting the development of new or adapted prevention and/or intervention tools and

measures, such as new or adapted diagnostic procedures and therapies, drugs, vaccines,

clinical disease management or disease vector control, or evidence-based public health, socio-




behavioural and socio-economic measures. Priority should be given to supporting research

projects targeting newly emerging virus variants, focusing on their detection, characterisation,

surveillance and assessment (changes in transmissibility and disease manifestation) and on the

adaptation of intervention and prevention measures (medication, vaccines, public health

measures) which likely also requires additional regulatory and clinical trials support.

Following the One-Health concept, services supporting research on transmission of pathogens

from animals to humans (or vice versa animals as host reservoir), including vector-borne

transmission, should be covered. Research infrastructures dealing with social science should

be involved to enable data acquisition enhancing understanding of individual and population

perceptions and behaviours in an epidemic setting, including public response to intervention

measures such as social distancing, vaccine campaigns, etc., over the course of an epidemic.

Flexibility in the provision of services should be properly demonstrated to ensure fast re-

orientation and expansion of the portfolio in response to unexpected epidemics situations,

including emerging threats posed by new SARS-CoV-2 variants. Effective operational links

to epidemics risk assessment and management bodies like ECDC, WHO, OIE, a possible

future EU Health Emergency preparedness and Response Authority (EU-HERA) and national

authorities are essential. Global standards, relevant data platforms and registries should be

used to make user project results openly available and usable, thus enabling further research

on pathogens, disease manifestation, behavioural research and other epidemics related social

science research.

Appropriate links should be ensured with the European Open Science Cloud (EOSC), the

European COVID-19 Data Platform and the newly established Population Health Information

Research Infrastructure for COVID-19 (PHIRI). Data management (and related ethics issues)

and interoperability should be addressed.

To identify and better exploit related synergies, share results and avoid overlaps, grants

awarded under this action should cooperate with those awarded under the Other action “FAIR

and open data sharing in support of European preparedness for COVID-19 and other

infectious diseases”. To this extent, proposals should provide for dedicated activities and

earmark appropriate resources.

Pandemics are global challenges and collaboration with relevant international partners should

be envisaged.

Proposals should adhere to the guidelines and principles of the European Charter for Access

to Research Infrastructures7.

Proposals should make available to researchers the widest and most comprehensive portfolio

of research infrastructures services which are relevant for the scope. To this extent, they

should involve, as beneficiaries or as third parties, the necessary interdisciplinary set of

7 https://ec.europa.eu/research/infrastructures/pdf/2016_charterforaccessto-ris.pdf

https://ec.europa.eu/research/infrastructures/pdf/2016_charterforaccessto-ris.pdf






research infrastructures of European interest8 that provide such services. The inclusiveness of

the proposal will be taken into account in the Excellence score.

Research infrastructures from third countries9 may be involved when appropriate, in particular

when they offer complementary or more advanced services, including data, than those

available in Europe.

Proposals could consider, for their inclusion in the service portfolio, relevant services and

expertise offered by the European Commission’s Joint Research Centre (JRC) , and in

particular by its Nanobiotechnology laboratories 10 , on high-end characterisation of

therapeutics against pandemics, including antibodies, viral antigens, vaccine nanocarriers,

and, more in general, on characterisation of nanomaterials, nanomedicines and advanced

materials.

Grants awarded under this action are expected to duly contribute to any future Partnership for

Pandemic Preparedness that might be established under Horizon Europe.

Proposals should include an outreach plan to actively advertise its services to targeted

research communities and, if applicable, to relevant industries, including SMEs.

Proposals are expected to exploit synergies and to ensure complementarity and coherence

with other EU grants supporting access provision.

Proposals will include the list of services/installations11 opened by research infrastructures for

trans-national or virtual access and the amounts of units of access made available for users.

Further conditions and requirements relating to access provisions that applicants should fulfil

when drafting a proposal are given in the “Specific features for Research Infrastructures”

section of this Work Programme. Compliance with these provisions will be taken into account

during evaluation.

Specific Conditions

The general conditions, including admissibility conditions, eligibility conditions, award

criteria, evaluation and award procedure, legal and financial set-up for grants, financial and

operational capacity and exclusion, and procedure are provided in parts A to G of the General

Annexes. The following topic specific conditions apply:

Admissibility conditions

Applicants are not required to submit a plan for the exploitation and dissemination of the

results, as the main objective of these actions is the service provision.

8 A research infrastructure is of European interest when is able to attract users from EU or associated

countries other than the country where the infrastructure is located. This includes ESFRI and ERIC infrastructures.

9 See the Eligibility conditions for this action. 10 For the participation of the JRC see General Annex B. 11 ‘Installation’ means a part or a service of a research infrastructure that can be used independently from

the rest. A research infrastructure consists of one or more installations.




As proposals need to give information on the research infrastructures providing access, the

page limit of the application is 100 pages.

Eligibility conditions

The Joint Research Centre (JRC) may participate as member of the consortium selected for

funding.

Given the specific nature of this action, access provision activities must be included in the

proposal. Please read carefully the provisions under the section “Specific features for

Research Infrastructures” at the end of this work programme part before prepar ing your

application.

Due to the urgency of this action and geographical relevance of this action and considering

the Union’s interest to retain, in principle, relations with the countries associated to Horizon

2020, and other third countries in the process of association to Horizon Europe, legal entities

established in Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland,

Israel, Kosovo 12 , Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia,

Switzerland, Tunisia, Turkey, Ukraine and United Kingdom are eligible for funding from the

Union even if the Horizon Europe association agreement with the third country concerned

does not apply at the time of signature of the grant agreement.

The consortium must include at least one independent legal entity established in a Member

State and at least two other independent legal entities each established in different Member

States or countries listed above.

Considering the Union’s interest to make accessible to its researchers the most advanced

research infrastructures, wherever they are in the world, legal entities established in Australia,

Brazil, Canada, China, India, Japan, Mexico, New Zealand, Republic of Korea, Russia,

Singapore and USA, which provide, under the grant, access to their research infrastructures to

researchers from Member States and Associated Countries, are exceptionally eligible for

funding from the Union under this topic.

Award criteria

For the ‘Excellence’ criterion, in addition to its standard sub-criteria, the following aspects

will also be taken into account:

The extent to which the access activities (trans-national and/or virtual access) will offer

access to the state-of-the-art infrastructures of European interest in the field, high quality

services, and will enable users to conduct excellent research.

The extent to which the project will contribute to facilitat ing and integrating the access

procedures, to improve the services the infrastructures provide and to further develop

their on-line services.

12 This designation is without prejudice to positions on status, and is in line with UNSCR 1244/1999 and

the ICJ Opinion on the Kosovo declaration of independence.




Procedure

The granting authority can fund a maximum of one project.

Legal and financial set-up of the Grant Agreements

Eligible costs may take form of unit costs for trans-national and virtual access to research

infrastructures as defined in the Decision authorising the use of unit costs for the actions

involving trans-national and virtual access (see Annex 2 of the Horizon Europe Model Grant

Agreement).

Form of Funding: Grants not subject to calls for proposals

Type of Action: Research and Innovation Actions - Grant awarded without call for proposals

in accordance with Article 195 (b) of the Financial Regulation

Indicative timetable: Second quarter 2021

Indicative budget: EUR 21.00 million from the 2021 budget




Budget13

Budget

line(s)

2021

Budget (EUR

million)

2022

Budget (EUR

million)

Other actions

Grant awarded without a call for proposals

in accordance with Article 195 (b) of the

Financial Regulation

33.00

from

01.020103

33.00

Estimated total budget 33.00

13 The budget figures given in this table are rounded to two decimal places.

The budget amounts are subject to the availability of the appropriations provided for in the general budget of the Union for years 2021 and 2022.




Specific Features for Research Infrastructure

This section provides further conditions and requirements on access provision that applicants

must comply with, for the ‘Research Infrastructure services for rapid research responses to

COVID-19 and other infectious disease epidemics’ action. Compliance with these provisions

will also be taken into account during evaluation.

Trans-national and/or virtual access14 activities.

Trans-national access activities

Trans-national access provision must be implemented as follows:

Trans-national access to infrastructure services offered under the grant is provided 'free of

charge' to selected researchers or research teams (user-groups) including from industry.

Access activities should be implemented in a coordinated way so as to improve the overall

service provision to the research community. Access may be made available to external users,

either in person (‘hands-on’), when the user visits the infrastructure to make use of it, or

through the provision to the user of remote scientific services, such as the provision of

reference materials or samples, the remote access to a high-performance computing facility,

the performance of sample analysis or sample deposition.

The research infrastructures must publicise widely the access offered under the grant

agreement to ensure that researchers who might wish to have access to the infrastructures are

made aware of the possibilities open to them. They must open specific calls to invite

researchers to apply for access. The research infrastructures must promote equal opportunities

in advertising the access and take into account gender issues when defining the support

provided to visitors. They must maintain appropriate documentation to support and justify the

amount of access reported. This documentation must include records of the names,

nationalities, and home institutions of the users within the research teams, as well as the

nature and quantity of access provided to them. To this extent , a unit of access to each

infrastructure service/installation 15 needs to be identified and precisely defined in the

proposal.

The selection of researchers or research teams must be carried out through an independent

peer-review evaluation of the research projects (user projects) they wish to carry out at the

infrastructure. The research team, or its majority, must work in countries other than the

country(ies) where the infrastructure is located (when the infrastructure is composed of

several research facilities, operated by different legal entities, this condition must apply to

each facility) except when access is provided by an International organisation, the Joint

Research Centre (JRC), an ERIC or similar legal entities with international membership. User

teams where all or the majority of users work in third countries can be supported as long as

14 See Annex 5 (Article 18) of Horizon Europe Model Grant Agreement 15 “Installation” means a part or a service of a research infrastructure that can be used independently from

the rest. A research infrastructure consists of one or more installations.




the cumulative access provided to them is below 20% of the total amount of units of access

provided under the grant. In exceptional and well justified cases a higher percentage of access

to third-country user teams can be set out in the proposal.

Only user groups that are allowed to disseminate the results they have generated under the

action may be eligible for access (unless the users are working for SMEs).

The duration of stay at a research infrastructure must normally be limited to three months,

unless otherwise provided for in the proposal.

The EU financial support to trans-national access will cover the access costs16 incurred by the

access provider in providing access to the selected researchers, as well as the travel and

subsistence costs incurred in supporting visits to the infrastructure of these researchers.

The access costs charged to the grant will not include capital investments (including

depreciation costs of equipment, infrastructure or other assets) nor internally invoiced goods

and services, unless otherwise specified in the Work Programme, while they may cover the

running costs of the infrastructure as well as the cost for the logistical, technological and

scientific support for users’ access. This includes costs for ad-hoc training users need to use

the infrastructure and for preparatory and closing activities that may be necessary to carry out

users’ work on the infrastructure.

Virtual access activities

Virtual access provision must be implemented as follows:

Virtual access to research infrastructure is provided through communication networks to users

complying with the RI’s access policy, without selecting them. Examples of virtual access

activities are provision of access to databases available via Internet, or data deposition

services.

The research infrastructures must publicise widely the access offered under the grant

agreement to ensure that researchers who might wish to have access to the infrastructures are

made aware of the possibilities open to them.

The EU financial support to virtual access will cover the access costs17 incurred by the

infrastructure in providing access under the project, including the technological and scientific

16 Access costs will be supported through the reimbursement of the eligible costs specifically incurred by

a research infrastructure for providing access to the research teams selected for support under the

project, or on the basis of unit costs calculated according to the methodology indicated in the Decision authorising the use of unit costs for the costs of providing trans -national and virtual access in Research Infrastructures actions under the Horizon Europe Programme. In the latter case the access costs will be

calculated multiplying the unit cost by the quantity of access provided under the grant. The cost of the unit of access to the infrastructure, i.e. the unit cost, must then be indicated in the proposal. A

combination of the two methods mentioned above will also be possible. 17 Access costs will be supported through the reimbursement of the eligible actual costs specifically

incurred by a research infrastructure for providing virtual access to identified users under the project, or

on the basis of unit costs calculated according to the methodology indicated in the Decision authorising the use of unit costs for the costs of providing trans-national and virtual access in Research Infrastructures actions under the Horizon Europe Programme. In the latter case, the access costs will be




support researchers need to effectively use the services. Capital investments (including

depreciation costs of equipment, infrastructure or other assets) as well as internally invoiced

goods and services will not be eligible costs unless otherwise specified under the specific call

or topic, in which case only the portion used to provide virtual access under the project can be

eligible. A unit of access to each research infrastructure service must be identified and

precisely defined in the proposal. The provision of virtual access during the project lifetime

will be measured through the units of access defined in the grant agreement and must be

periodically assessed by an external board. Eligibility criteria (e.g. affiliation to a research or

academic institution) for users can be defined in the proposal, to take into account the access

policies of the different RIs.

calculated multiplying the unit cost by the quantity of access provided under the grant. The cost of the unit of access to the research infrastructure, i.e. the unit cost, must then be indicated in the proposal. A combination of the two methods mentioned above will also be possible.

Documents

3. Research Infrastructures